Skip to content
Takeda Pharmaceuticals International GmbH
Contact us
Sitemap
Downloads
Worldwide Websites
Takeda Global
Takeda Pharmaceuticals International GmbH
Argentina
Armenia
Australia
Austria
Azerbaijan
Belarus
Belgium
Brazil
Bulgaria
Canada
中国 (China)
Croatia
Czech Republic
Denmark
Estonia
Finland
Georgia
Germany
Greece
Hungary
India
Italy
Kazakhstan
Latvia
Lithuania
Mexico
Netherlands
Norway
Poland
Russia
Slovakia
South Africa
Spain
Sweden
Switzerland
Takeda Global
Turkey
Ukraine
United Kingdom
Uzbekistan
About Us
Global Reach
Partnerships
Research and Development
Corporate Philosophy
Corporate Responsibility
Products
Manufacturing
Contract Manufacturing
Global Presence
Media
Press Releases
Media Resources
Subscription
Careers
Who We Are
What We Seek
What We Offer
How to Join Us
Open Positions
Committed to striving towards better health
for patients worldwide through leading
innovation in medicine.
More about Takeda
Committed to striving towards better health
for patients worldwide through leading
innovation in medicine.
More about Takeda
Committed to striving towards better health
for patients worldwide through leading
innovation in medicine.
More about Takeda
Partnerships
We are dedicated to partnerships.
More
Products / Pipeline
close
Products by Name
Products by Name
Open
close
Products by Therapeutic Areas
no title set
no title set
no title set
no title set
no title set
no title set
Products by Therapeutic Areas
Open
close
Clinical Pipeline Projects
Phase I
Phase II
Phase III
Registration
PDE4 Inhibitor
Inflammation, Respiratory
More
Saber™-bupivacaine (Optesia®)
Incisional pain
More
Alendronate effervescent
Osteoporosis
More
MT203
Inflammation
More
Veltuzumab
Rheumatoid arthritis
More
Teduglutide (Revestive®)
Short bowel syndrome
More
Ciclesonide HFA nasal
Allergic rhinitis
More
Clinical Pipeline Projects
Open
More
Career Opportunities
We are always searching for talented people to join our team.
Careers
R&D
Addressing unmet medical needs.
R&D
News
22.04.2013
Takeda and Sanofi Sign Co-promotion Agreement to Expand Reach of Diabetes Treatment Alogliptin in China
21.03.2013
Takeda Launches New Subsidiary in Ecuador
Media
Top of page